A major focus of academia, industry, and global governmental agencies is to develop and apply artificial intelligence and other advanced analytical tools to transform health care delivery. The American Heart Association supports the creation of tools and services that would further the science and practice of precision medicine by enabling more precise approaches to cardiovascular and stroke research, prevention, and care of individuals and populations. Nevertheless, several challenges exist, and few artificial intelligence tools have been shown to improve cardiovascular and stroke care sufficiently to be widely adopted. This scientific statement outlines the current state of the art on the use of artificial intelligence algorithms and data science in the diagnosis, classification, and treatment of cardiovascular disease. It also sets out to advance this mission, focusing on how digital tools and, in particular, artificial intelligence may provide clinical and mechanistic insights, address bias in clinical studies, and facilitate education and implementation science to improve cardiovascular and stroke outcomes. Last, a key objective of this scientific statement is to further the field by identifying best practices, gaps, and challenges for interested stakeholders.

中文翻译：

---

使用人工智能改善心脏病的治疗效果：美国心脏协会的科学声明

学术界、工业界和全球政府机构的主要关注点是开发和应用人工智能和其他先进分析工具来改变医疗保健服务。美国心脏协会支持创建工具和服务，通过为个人和人群提供更精确的心血管和中风研究、预防和护理方法，进一步推动精准医学的科学和实践。然而，仍然存在一些挑战，而且很少有人工智能工具被证明能够充分改善心血管和中风护理并得到广泛采用。这份科学声明概述了人工智能算法和数据科学在心血管疾病的诊断、分类和治疗中的最新技术应用。它还着手推进这一使命，重点关注数字工具，特别是人工智能如何提供临床和机制见解，解决临床研究中的偏见，并促进教育和实施科学，以改善心血管和中风的结果。最后，本科学声明的一个关键目标是通过为感兴趣的利益相关者确定最佳实践、差距和挑战来进一步推动该领域的发展。